Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. - Stewart S; Seco-Meseguer E; Diago-Sempere E; Marín-Candón A; Carmona M; Estébanez M; López-Fernández LA; Imaz-Iglesia I; Del Mar García Saiz M; Laserna-Mendieta EJ; Peiró AM; Farré M; et al. (BMJ open, 2024)